Please be advised that the Company will be retiring the following official Facebook and X (formerly Twitter) accounts at the end of December 2023:
Facebook https://www.facebook.com/SantenOfficial
X (formerly Twitter) https://twitter.com/SantenOfficial https://twitter.com/SantenGlobal
Since their establishment, the official Facebook and X (formerly Twitter) accounts have regularly distributed a variety of information related to Santen, eliciting comments and “likes” from many people. We would like to thank everyone for their comments, likes, and support.
Looking ahead, the Company plans to further expand the official corporate website to provide a broader variety of information to a greater number of people. The official LinkedIn account will continue to be used to share information with Santen’s global audiences.
Official corporate website (Japanese) https://www.santen.com/ja
Official corporate website (English) https://www.santen.com/en
Official LinkedIn account https://linkedin.com/company/santen-pharmaceutical
We look forward to your continued support.
Contact
Corporate Communications
Santen Pharmaceutical Co., Ltd.
E-mail: communication@santen.com